» Articles » PMID: 34079084

Long Non-coding RNA Lnc-408 Promotes Invasion and Metastasis of Breast Cancer Cell by Regulating LIMK1

Overview
Journal Oncogene
Date 2021 Jun 3
PMID 34079084
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Invasion and metastasis are the leading causes of death in patients with breast cancer (BC), and epithelial-mesenchymal transformation (EMT) plays an essential role in this process. Here, we found that Lnc-408, a novel long noncoding RNA (lncRNA), is significantly upregulated in BC cells undergoing EMT and in BC tumor with lymphatic metastases compared with those without lymphatic metastases. Lnc-408 can enhance BC invasion and metastasis by regulating the expression of LIMK1. Mechanistically, Lnc-408 serves as a sponge for miR-654-5p to relieve the suppression of miR-654-5p on its target LIMK1. Knockdown or knockout of Lnc-408 in invasive BC cells clearly decreased LIMK1 levels, and ectopic Lnc-408 in MCF-7 cells increased LIMK1 expression to promote cell invasion. Lnc-408-mediated enhancement of LIMK1 plays a key role in cytoskeletal stability and promotes invadopodium formation in BC cells via p-cofilin/F-actin. In addition, the increased LIMK1 also facilitates the expression of MMP2, ITGB1, and COL1A1 by phosphorylating CREB. In conclusion, our findings reveal that Lnc-408 promotes BC invasion and metastasis via the Lnc-408/miR-654-5p/LIMK1 axis, highlighting a novel promising target for the diagnosis and treatment of BC.

Citing Articles

Identification of LIMK1 as a biomarker in clear cell renal cell carcinoma: from data mining to validation.

Li Y, Fan C, Jiang F, Zhang J, Li Y, Jiang Y J Cancer Res Clin Oncol. 2025; 151(3):104.

PMID: 40056237 PMC: 11890329. DOI: 10.1007/s00432-025-06146-5.


CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance.

Xu X, Peng Q, Ren Z, Han Y, Jiang X, Wu Z Mol Cancer. 2025; 24(1):36.

PMID: 39891203 PMC: 11783750. DOI: 10.1186/s12943-025-02239-4.


Tumor-derived exosomal lncRNA-MIR193BHG promotes bone metastasis of breast cancer by targeting the miR-489-3p/DNMT3A signaling axis in osteoclasts.

Liu X, Ma R, Wei F, Wang M, Jiang Y, Zheng P J Transl Med. 2025; 23(1):142.

PMID: 39891171 PMC: 11786480. DOI: 10.1186/s12967-025-06156-4.


Molecular Mechanism of lncRNAs in Regulation of Breast Cancer Metastasis; a Comprehensive Review.

Ahmadi S, Yazdi F, Khastar S, Kaur I, Ahmed M, Kumar A Cell Biochem Biophys. 2024; 83(1):229-245.

PMID: 39367197 DOI: 10.1007/s12013-024-01535-y.


Integrin β1 in breast cancer: mechanisms of progression and therapy.

Huang Q, Wang J, Ning H, Liu W, Han X Breast Cancer. 2024; 32(1):43-59.

PMID: 39343856 DOI: 10.1007/s12282-024-01635-w.


References
1.
Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

2.
Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66(4):271-89. DOI: 10.3322/caac.21349. View

3.
Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S . Identification of the tumour transition states occurring during EMT. Nature. 2018; 556(7702):463-468. DOI: 10.1038/s41586-018-0040-3. View

4.
Mitra A, Mishra L, Li S . EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 2015; 6(13):10697-711. PMC: 4484413. DOI: 10.18632/oncotarget.4037. View

5.
Perkel J . Visiting "noncodarnia". Biotechniques. 2013; 54(6):301, 303-4. DOI: 10.2144/000114037. View